NTCB02-1
- Generic Name
- NTCB02-1
Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT06625957
- Locations
- 🇰🇷
National Cancer Center, Gyeonggi-do, Goyang-si, Korea, Republic of
🇰🇷Chonnam National University Hwasun Hospital, Jeollanam-do, Hwasun-gun, Korea, Republic of
🇰🇷Jeonbuk National University Hospital, Jeollabuk-do, Jeonju-si, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath